Documents
Application Sponsors
ANDA 078976 | ACTAVIS MID ATLANTIC | |
Marketing Status
Application Products
001 | SOLUTION;ORAL | 100MG/ML | 0 | LEVETIRACETAM | LEVETIRACETAM |
FDA Submissions
| ORIG | 1 | AP | 2009-01-15 | |
REMS; REMS | SUPPL | 3 | AP | 2010-02-16 | |
LABELING; Labeling | SUPPL | 4 | AP | 2010-11-17 | |
LABELING; Labeling | SUPPL | 6 | AP | 2014-09-26 | STANDARD |
LABELING; Labeling | SUPPL | 9 | AP | 2014-09-26 | STANDARD |
LABELING; Labeling | SUPPL | 11 | AP | 2014-09-26 | STANDARD |
LABELING; Labeling | SUPPL | 13 | AP | 2014-09-26 | STANDARD |
Submissions Property Types
SUPPL | 3 | Null | 7 |
SUPPL | 6 | Null | 7 |
SUPPL | 9 | Null | 15 |
SUPPL | 11 | Null | 15 |
SUPPL | 13 | Null | 15 |
TE Codes
CDER Filings
ACTAVIS MID ATLANTIC
cder:Array
(
[0] => Array
(
[ApplNo] => 78976
[companyName] => ACTAVIS MID ATLANTIC
[docInserts] => ["",""]
[products] => [{"drugName":"LEVETIRACETAM","activeIngredients":"LEVETIRACETAM","strength":"100MG\/ML","dosageForm":"SOLUTION;ORAL","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"}]
[labels] =>
[originalApprovals] => [{"actionDate":"LEVETIRACETAM","submission":"LEVETIRACETAM","actionType":"100MG\/ML","submissionClassification":"SOLUTION;ORAL","reviewPriority":"Prescription","inserts":"[]","notes":">No"}]
[supplements] =>
[actionDate] => 1969-12-31
)
)